151 related articles for article (PubMed ID: 6323815)
1. Serum ceruloplasmin and copper levels in patients with primary brain tumors.
Turecký L; Kalina P; Uhlíková E; Námerová S; Krizko J
Klin Wochenschr; 1984 Feb; 62(4):187-9. PubMed ID: 6323815
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of lymphocyte populations and T cell subsets in patients with intracranial glioma.
Lin SM; Lee CS; Hung CC
Taiwan Yi Xue Hui Za Zhi; 1985 Feb; 84(2):173-80. PubMed ID: 2989415
[No Abstract] [Full Text] [Related]
3. [Immunoenzyme method of determining brain-specific alpha 1-globulin in glial tumors].
Tatarinov IuS; Obukhov SK
Vopr Onkol; 1985; 31(1):76-9. PubMed ID: 2579508
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of plasma tissue factor pathway inhibitor in patients with glioblastoma and intracerebral metastases.
Gerlach R; Scheuer T; Böhm M; Beck J; Woszczyk A; Raabe A; Scharrer I; Seifert V
Neurol Res; 2003 Jun; 25(4):335-8. PubMed ID: 12870258
[TBL] [Abstract][Full Text] [Related]
5. Comparison of some serum copper parameters in trained runners and control subjects.
Resina A; Fedi S; Gatteschi L; Rubenni MG; Giamberardino MA; Trabassi E; Imreh F
Int J Sports Med; 1990 Feb; 11(1):58-60. PubMed ID: 2318564
[TBL] [Abstract][Full Text] [Related]
6. Evidence for increased non-ceruloplasmin copper in early-stage human breast cancer serum.
Dabek JT; Hyvönen-Dabek M; Härkönen M; Adlercreutz H
Nutr Cancer; 1992; 17(2):195-201. PubMed ID: 1584712
[TBL] [Abstract][Full Text] [Related]
7. Changes in copper and ceruloplasmin in chronic renal insufficiency treated by hemodialysis and peritoneal dialysis.
Bustamante J; Martin Mateo MC; De Paula de Pedro A; Ortiz Manchado O
Nephron; 1978; 22(4-6):312-5. PubMed ID: 740091
[TBL] [Abstract][Full Text] [Related]
8. The value of serum zinc, copper, ceruloplasmin levels in patients with gastrointestinal tract cancers.
Boz A; Evliyaoğlu O; Yildirim M; Erkan N; Karaca B
Turk J Gastroenterol; 2005 Jun; 16(2):81-4. PubMed ID: 16252197
[TBL] [Abstract][Full Text] [Related]
9. [The glio-fibrillar acid protein in blood serum of patients with brain tumors and neurological diseases of non-tumorous etiology].
Lyubimova NV; Timofeiev YS; Sushlinskii NE
Klin Lab Diagn; 2016 Aug; 61(8):466-9. PubMed ID: 30601636
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic profiling of blood plasma in patients with primary brain tumours: Basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects - a preliminary study.
Baranovičová E; Galanda T; Galanda M; Hatok J; Kolarovszki B; Richterová R; Račay P
IUBMB Life; 2019 Dec; 71(12):1994-2002. PubMed ID: 31419008
[TBL] [Abstract][Full Text] [Related]
11. Serum ceruloplasmin and copper are early biomarkers for traumatic brain injury-associated elevated intracranial pressure.
Dash PK; Redell JB; Hergenroeder G; Zhao J; Clifton GL; Moore A
J Neurosci Res; 2010 Jun; 88(8):1719-26. PubMed ID: 20091772
[TBL] [Abstract][Full Text] [Related]
12. Serum ceruloplasmin, plasma copper concentration and copper to ceruloplasmin ratio in cervical carcinoma.
Arumanayagam M; Wong FW; Rogers M; Swaminathan R
Gynecol Obstet Invest; 1993; 35(3):175-8. PubMed ID: 8505012
[TBL] [Abstract][Full Text] [Related]
13. [ON RADIOTHERAPY OF PRIMARY BRAIN TUMORS. RESULTS, TECHNIC AND EVALUATION].
WENDE S; HERMS HJ
Strahlentherapie; 1963 Sep; 122():16-26. PubMed ID: 14093428
[No Abstract] [Full Text] [Related]
14. Copper and ceruloplasmin levels in serum of women with breast cancer.
Vaidya SM; Kamalakar PL
Indian J Med Sci; 1998 May; 52(5):184-7. PubMed ID: 9808908
[TBL] [Abstract][Full Text] [Related]
15. Copper and ceruloplasmin status in serum of prostate and colon cancer patients.
Nayak SB; Bhat VR; Upadhyay D; Udupa SL
Indian J Physiol Pharmacol; 2003 Jan; 47(1):108-10. PubMed ID: 12708132
[TBL] [Abstract][Full Text] [Related]
16. Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications.
Conforti A; Franco L; Menegale G; Milanino R; Piemonte G; Velo GP
Pharmacol Res Commun; 1983 Oct; 15(9):859-67. PubMed ID: 6647528
[TBL] [Abstract][Full Text] [Related]
17. Elevation of serum ceruloplasmin levels in brain tumours.
Manjula S; Aroor AR; Raja A; Rao SN; Rao A
Acta Neurol Scand; 1992 Aug; 86(2):156-8. PubMed ID: 1414225
[TBL] [Abstract][Full Text] [Related]
18. [POSSIBILITIES AND LIMITATIONS OF RADIOISOTOPES (CU-64 AND AS-74) IN THE DIAGNOSIS OF BRAIN TUMORS].
WILCKE O
Neurochirurgia (Stuttg); 1964 Feb; 7():33-41. PubMed ID: 14138671
[No Abstract] [Full Text] [Related]
19. Serum IgM level as an index of malignancy in brain tumours.
Hekim N; Sayin E; Demirkaya E; Berkay F
Acta Neurochir (Wien); 1981; 59(3-4):227-30. PubMed ID: 6280452
[No Abstract] [Full Text] [Related]
20. Serum copper and ceruloplasmin levels and urinary copper excretion in thermal injury.
Boosalis MG; McCall JT; Solem LD; Ahrenholz DH; McClain CJ
Am J Clin Nutr; 1986 Dec; 44(6):899-906. PubMed ID: 3788837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
